Brazil drugmaker eyes contract, regulatory OK for Russian vaccine next week

Reuters · 02/05/2021 19:41
Brazil drugmaker eyes contract, regulatory OK for Russian vaccine next week

- Brazilian pharmaceutical company União Química expects health regulator Anvisa to approve emergency use of Russia's Sputnik V vaccine against COVID-19 next week, its director for international business Rogerio Rosso told Reuters on Friday.

Rosso said the company expects to draw up a contract by Wednesday with the Health Ministry for an initial 10 million imported doses based on a reference price of $10 per dose. He said the ministry is also interested in buying the firm's entire domestic production of Sputnik V, an estimated 8 million doses a month from April, for Brazil's national immunization program.


(Reporting by Anthony Boadle
Editing by Brad Haynes)

((anthony.boadle@tr.com +55 61 98204-1110; https://twitter.com/anthonyboadle ;))